difficile-associated diarrhoea during the first 6 months of 1995 were analysed retrospectively. The majority of the patients (106) had received antibiotics before the onset of diarrhoea; 46 had received three or more different antibiotics and 28 had received metronidazole. In 19 patients, the first stool sample after the onset of diarrhoea was negative for C difficile cytotoxin, with a mean delay of 8.2 days before a positive stool sample. We conclude that C difficile-associated diarrhoea was associated with the usage of multiple antibiotics, and that metronidazole did not protect against colonisation by C difficile.
Summary
At our hospital, the number of cases of Clostridium difficile-associated diarrhoea increased from 29 in 1993 to 210 in 1995. The case notes of 110 patients with C difficile-associated diarrhoea during the first 6 months of 1995 were analysed retrospectively. The majority of the patients (106) had received antibiotics before the onset of diarrhoea; 46 had received three or more different antibiotics and 28 had received metronidazole. In 19 patients, the first stool sample after the onset of diarrhoea was negative for C difficile cytotoxin, with a mean delay of 8.2 days before a positive stool sample. We conclude that C difficile-associated diarrhoea was associated with the usage of multiple antibiotics, and that metronidazole did not protect against colonisation by C difficile.
We also recommend that more than one stool sample should be tested for the C difficile cytotoxin.
Keywords: Clostridium difficile; diarrhoea; metronidazole 
of CDAD. They included two on clarithromycin (both also on metronidazole), two on trimethoprim alone and one each on trimethoprim and ofloxacin, ciprofloxacin, or flucloxacillin. Four patients did not receive any antibiotics in hospital prior to the onset of CDAD and review of their general practitioner records revealed that three had not received any antibiotics in the preceding 12 months.
The median (range) interval between the day of admission and the onset of diarrhoea was 19.4 days (1-151). In 19 (17%) patients the first stool sample after the onset of diarrhoea was negative for the cytotoxin, with a mean (+ SD) delay of 8.2 (± 6.6) days before a positive stool sample (second sample in all cases). The median (range) duration of hospital stay for all patients with CDAD was 42 days (12-269) days. Fifty-one (46%) patients died in hospital. Discussion C difficile infection is an increasing problem in hospitalised patients. Elderly patients on antibiotics, particularly cephalosporin and broadspectrum penicillin, appear to be particularly susceptible.2 Our study has shown that the majority of patients had received two or more different antibiotics prior to the onset of CDAD. Colonisation with C difficile occurs following disruption of the normal colonic flora by antibiotics' and our studies suggest that multiple antibiotics may increase the risk of infection due to a greater degree of disruption of the microflora. However, three patients with CDAD had not received any antibiotic for at least 12 months prior to the onset of diarrhoea, suggesting a role for other factors in disruption of the normal colonic flora. The only other drugs that these three patients had received were antihypertensive drugs (angiotensinconverting enzyme inhibitors and diuretics) and/or bronchodilators (including inhaled corticosteroids).
Metronidazole and vancomycin have been reported to be equally efficacious in the treatment of C difficile-associated disease.4 We were therefore surprised to find that 26.4% of patients had received metronidazole prior to the onset of CDAD, including 8% who were on the drug at the time of the onset of diarrhoea. Although there are reports of CDAD associated with the ingestion of metronidazole,5 we believe this is the first report of such a large number of patients who developed CDAD after receiving metronidazole. All the patients on metronidazole were also taking other antibiotics, including two on clarithromycin. We have recently also managed a 79-year-old patient who developed pseudomembranous colitis (C difficile toxin positive) in the community while taking omeprazole, amoxycillin and metronidazole for eradication of Helicobacter pylori. Since metronidazole and clarithromycin or amoxycillin, together with potent acid suppression, are frequently used to eradicate H pylori,6 use of this combination of drugs in the elderly may predispose to CDAD. A possible explanation for the failure of metronidazole to protect against colonisation by C difficile is that inadequate levels of the drug were achieved in the colonic lumen of these patients.
Another important aspect of our study is the finding that in 17% of patients, analysis of the first stool sample was negative for C difficile cytotoxin. It is possible that, at the time the first (negative) stool sample was obtained, the patients were not colonised with toxigenic C difficile but had acquired the organism by the time the second (positive) stool sample was taken. However, since the patients had diarrhoea on both occasions (and also in the intervening period), we believe the more likely explanation is that the first stool sample was falsely negative for C difficile cytotoxin. Appreciation of this possibility is important in clinical practice as there was a mean delay of 8.2 days before a cytotoxin-positive stool sample was reported, leading to a delay in the institution of appropriate treatment. The assay used for the detection of C difficile toxin is based on the demonstration of cytotoxicity in a mammalian cell line and is considered to be the gold standard.7 Early sigmoidoscopic examination in patients with significant diarrhoea may show the presence of mucosal inflammation, with characteristic histological appearances on biopsy,8 and is likely to be helpful in the early diagnosis and assessment of patients with CDAD.
